Retracted: Long‐term efficacy and safety of blonanserin in patients with first‐episode schizophrenia: A 1‐year open‐label trial

Abstract

Blonanserin was well tolerated and effective for the treatment of first-episode schizophrenia in terms of subjective wellness, cognition, and a wide range of pathological symptoms. Further large-scale studies are warranted to confirm our findings.